Increased rates of periprosthetic joint infection following hip hemiarthroplasty with clindamycin prophylaxis compared to cefazolin
- 15 February 2025
- journal article
- research article
- Published by Springer Nature in Archives of orthopaedic and trauma surgery
- Vol. 145 (1) , 1-8
Abstract
Purpose To compare the efficacy of clindamycin versus cefazolin in preventing periprosthetic joint infection (PJI) in patients undergoing hip hemiarthroplasty (HA) for femoral neck fractures. Methods This retrospective cohort study included 1,139 patients aged ≥ 65 years who underwent HA for femoral neck fractures between January 2017 and October 2023. Patients received either Cefazolin + Gentamicin (n = 1001) or Clindamycin + Gentamicin (n = 138). Propensity score matching was performed at a 6:1 ratio, resulting in 828 patients in the cefazolin group and 138 in the clindamycin group. PJI rates, causative organisms, and mortality were compared. Multivariate logistic regression adjusted for potential confounders. Results The PJI rate was significantly higher in the clindamycin group compared to the cefazolin group (7.2% vs. 3.5%, p = 0.042). Multivariate analysis confirmed that clindamycin prophylaxis was independently associated with increased PJI risk (adjusted OR = 2.41, 95% CI: 1.16–4.99, p = 0.018). Other independent risk factors for PJI included age (adjusted OR = 1.03 per year, 95% CI: 1.01–1.05, p = 0.045), diabetes mellitus (adjusted OR = 1.76, 95% CI: 1.10–2.81, p = 0.018), and surgery duration (adjusted OR = 1.07 per minute, 95% CI: 1.01–1.16, p = 0.035). Staphylococcus aureus was the most common pathogen, with no significant differences in bacterial distribution between the groups. No significant differences were found in 30-day or 1-year mortality rates. Conclusion Clindamycin prophylaxis in hip hemiarthroplasty for femoral neck fractures is associated with a significantly higher risk of PJI compared to cefazolin. These findings support the preferential use of cefazolin in patients without contraindications and demonstrate the critical need for accurate assessment of reported beta-lactam allergies. Results suggest potential benefit from pre-operative allergy evaluation when feasible, as alternative prophylaxis choices may carry increased infection risk. Further research is needed to explore alternative prophylactic strategies for patients with beta-lactam allergies.Keywords
This publication has 38 references indexed in Scilit:
- Is Vancomycin-only Prophylaxis for Patients With Penicillin Allergy Associated With Increased Risk of Infection After Arthroplasty?Clinical Orthopaedics and Related Research, 2016
- Patient-Related Risk Factors for Periprosthetic Joint Infection after Total Joint Arthroplasty: A Systematic Review and Meta-AnalysisPLOS ONE, 2016
- Prophylaxis with Teicoplanin and Cefuroxime Reduces the Rate of Prosthetic Joint Infection after Primary ArthroplastyAntimicrobial Agents and Chemotherapy, 2015
- Penicillin and Cephalosporin allergyAnnals of Allergy, Asthma & Immunology, 2014
- Are hip hemiarthroplasty and total hip arthroplasty infections different entities? The importance of hip fracturesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2014
- Hemiarthroplasties after Hip Fractures in Norway and Sweden: A Collaboration between the Norwegian and Swedish National RegistriesHIP International, 2014
- Microbiological Aetiology, Epidemiology, and Clinical Profile of Prosthetic Joint Infections: Are Current Antibiotic Prophylaxis Guidelines Effective?Antimicrobial Agents and Chemotherapy, 2012
- The Use of Cephalosporins in Penicillin-allergic Patients: A Literature ReviewThe Journal of Emergency Medicine, 2012
- New Definition for Periprosthetic Joint Infection: From the Workgroup of the Musculoskeletal Infection SocietyClinical Orthopaedics and Related Research, 2011
- Periprosthetic Infection Due to Resistant Staphylococci: Serious Problems on the HorizonClinical Orthopaedics and Related Research, 2009